Eli Lilly & Company

Pharmaceutical/ Health Products

Based in DC

🤖

AI Overview

With $1.5M in lobbying spend across 30 quarterly filings, Eli Lilly & Company is a significant lobbying presence. They deploy 17 individual lobbyists

$1.5M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
17
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$150K
2019$200K
2020$200K
2021$200K
2022$200K
2023$200K
2024$150K
2025$200K

Lobbying Firms

WILLIAMS AND JENSEN, PLLC

What They Lobby For

  • Medicare Part D. CMMI Medicare Part B Demonstration, education about policies impacting reimbursement.
  • General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and counterfeiting; FDA user fees; H.R. 1628, American Health Care Act of 2017.
  • Policies impacting Medicare Part D, H.R. 1625, Consolidated Appropriations Act. H.R. 1892, the Bipartisan Budget Act of 2018.
  • International and domestic tax issues. Implementation of H.R. 1, Tax Cuts and Jobs Act.
  • General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and counterfeiting; FDA user fees.
  • International and domestic tax issues. Implementation of H.R. 1, Tax Cuts and Jobs Act, (P.L. 115-97).
  • Medicare Part D. CMMI Medicare Part B Demonstration, education about policies impacting reimbursement. H.R. 6, Support for Policies and Communities Act.
  • Policies impacting Medicare Part D.
  • Implementation of the Tax Cuts and Jobs Act (P.L. 115-97).
  • General education about policies impacting pharmaceutical development, approval and reimbursement.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.